Mansour, S., Tocheva, A. S., Sanderson, J. P., Goulston, L. M., Platten, H., Serhal, L., Parsons, C., Edwards, M. H., Woelk, C. H., Elkington, P. T., Elliott, T., Cooper, C., Edwards, C. J., Gadola, S. D. (2015). Structural and Functional Changes of the Invariant NKT Clonal Repertoire in Early Rheumatoid Arthritis J Immunol 195(12): 5582-5591.

Ceroni, A., Higgins, G. S., Ebner, D. V. (2016). In Vitro-Pooled shRNA Screening to Identify Determinants of Radiosensitivity Methods Mol Biol 1470: 103-119.

Pace, M., Williams, J., Kurioka, A., Gerry, A. B., Jakobsen, B., Klenerman, P., Nwokolo, N., Fox, J., Fidler, S., Frater, J. (2016). Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function PLoS Pathog 12(8): e1005782.

Planchard, D., Kim, T. M., Mazieres, J., Quoix, E., Riely, G., Barlesi, F., Souquet, P. J., Smit, E. F., Groen, H. J., Kelly, R. J., Cho, B. C., Socinski, M. A., Pandite, L., Nase, C., Ma, B., D'Amelio, A., Jr., Mookerjee, B., Curtis, C. M., Jr., Johnson, B. E.. (2016). Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial Lancet Oncol 17(5): 642-650.

Singh, N., Kulikovskaya, I., Barrett, D. M., Binder-Scholl, G., Jakobsen, B., Martinez, D., Pawel, B., June, C. H., Kalos, M. D., Grupp, S. A. (2016). T cells targeting NY-ESO-1 demonstrate efficacy against disseminated neuroblastoma Oncoimmunology 5(1): e1040216.

Tan, M. P., Dolton, G. M., Gerry, A. B., Brewer, J. E., Bennett, A. D., Pumphrey, N., Jakobsen, B. K., Sewell, A. K. (2016). HLA class I-redirected anti-tumour CD4+ T-cells require a higher TCR binding affinity for optimal activity than CD8+ T-cells Clin Exp Immunol.

Tan MP, Gerry AB, Melchiori L, Bennett AD, Jakobsen BK, Ladell K, Brewer JE, Bridgeman JS, Pumphrey NJ, Price DA and Sewell AK. (2014) T cell receptor binding affinity governs the functional profile of cancer-specific CD8+T cells Clinical & Experimental Immunology. 2014;180:255-70.

Rapoport AP, Stadtmauer EA, Binder-Scholl GK, et al. (2015) NY-ESO-1 Specific TCR Engineered T-cells Mediate Sustained Antigen-specific Antitumor Effects in Myeloma Nat Med (21). July 2015; 914–921. doi:10.1038/nm.3910.

Bossi G, Gerry AB, Paston SJ, Sutton DH, Hassan NJ & Jakobsen BK. (2013) Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells Oncoimmunology. 2013 Nov 1; 2(11):e26840.

Cameron BJ, Gerry AB, Dukes J, Harper JV, Kannan V, Bianchi FC, Grand F, Brewer JE, Gupta M, Plesa G, Bossi G, Vuidepot A, Powlesland AS, Legg A, Adams KJ, Bennett AD, Pumphrey NJ, Williams DD, Binder-Scholl G, Kulikovskaya I, Levine BL, Riley JL, Varela-Rohena A, Stadtmauer EA, Rapoport AP, Linette GP, June CH, Hassan NJ, Kalos M, Jakobsen BK. (2013) Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE-A3-directed T cells
Sci Transl Med. 2013 Aug 7; 5(197):197ra103.

Linette GP, Stadtmauer EA, Maus MV, Rapoport AP, Levine BL, Emery L, Litzky L, Bagg A, Carreno BM, Cimino PJ, Binder-Scholl GK, Smethurst DP, Gerry AB, Pumphrey NJ, Bennett AD, Brewer JE, Dukes J, Harper J, Tayton-Martin HK, Jakobsen BK, Hassan NJ, Kalos M, June CH. (2013) Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
Blood. 2013 Aug 8; 122(6):863-71. doi: 10.1182/blood-2013-03-490565.

Smethurst D. (2013) A pharmacologic perspective on newly emerging T-cell manipulation technologies Br J Clin Pharmacol. 2013 Aug; 76(2):173-87. doi: 10.1111/j.1365-2125.2012.04475.x.

Liddy N, Bossi G, Adams KJ, Lissina A, Mahon TM, Hassan NJ, Gavarret J, Bianchi FC, Pumphrey NJ, Ladell K, Gostick E, Sewell AK, Lissin NM, Harwood NE, Molloy PE, Li Y, Cameron BJ, Sami M, Baston EE, Todorov PT, Paston SJ, Dennis RE, Harper JV, Dunn SM, Ashfield R, Johnson A, McGrath Y, Plesa G, June CH, Kalos M, Price DA, Vuidepot A, Williams DD, Sutton DH, Jakobsen BK. (2012) Monoclonal TCR-redirected tumor cell killing. Nat Med. 2012 May 6

Robbins PF, Li YF, El-Gamil M, Zhao Y, Wargo JA, Zheng Z, Xu H, Morgan RA, Feldman SA, Johnson LA, Bennett AD, Dunn SM, Mahon TM, Jakobsen BK, Rosenberg SA. (2008) Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions J Immunol. 2008 May 1; 180(9):6116-31.

Varela-Rohena, A., Molloy, P. E., Dunn, S. M., Li, Y., Suhoski, M., Carroll, R. G., Milicic, A., Mahon, T., Sutton, D. H., Laugel, B. E., Moysey, R., Cameron, B. J., Vuidepot, A., Purbhoo, M. E., Cole, D. K., Phillips, R. E., June, C. H., Jakobsen, B. K., Sewell, A. K., and Riley, J. L. (2008) Control of HIV-1 immune escape by CD8 T-cells expressing enhanced T-cell receptor. Nat Med. 14 (12), 1390-5.

Zhao Y, Bennett AD, Zheng Z, Wang QJ, Robbins PF, Yu LY, Li Y, Molloy PE, Dunn SM, Jakobsen BK, Rosenberg SA, Morgan RA. (2007) High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines J Immunol. 2007 Nov 1; 179(9):5845-54.

Cole DK, Pumphrey NJ, Boulter JM, Sami M, Bell JI, Gostick E, Price DA, Gao GF, Sewell AK, Jakobsen BK. (2007) Human TCR-binding affinity is governed by MHC class restriction. J Immunol. 2007 May 1;178(9):5727-34.

Yuan F, Georgiou T, Hillon T, Gostick E, Price DA, Sewell AK, Moysey R, Gavarret J, Vuidepot A, Sami M, Bell JI, Gao GF, Rizkallah PJ, Jakobsen BK. (2007) Crystallization and preliminary X-ray structural studies of a Melan-A pMHC-TCR complex. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007 Sep 1;63(Pt 9):758-60.

Sami Malkit; Rizkallah Pierre J; Dunn Steve; Molloy Peter; Moysey Ruth; Vuidepot Annelise; Baston Emma; Todorov Penio; Li Yi; Gao Feng; Boulter Jonathan M; Jakobsen Bent K. (2007) Crystal structures of high affinity human T-cell receptors bound to peptide major histocompatibility complex reveal native diagonal binding geometry. Protein engineering, design & selection : PEDS 2007;20(8):397-403.

Purbhoo Marco A; Li Yi; Sutton Deborah H; Brewer Joanna E; Gostick Emma; Bossi Giovanna; Laugel Bruno; Moysey Ruth; Baston Emma; Liddy Nathaniel; Cameron Brian; Bennett Alan D; Ashfield Rebecca; Milicic Anita; Price David A; Classon Brendan J; Sewell Andrew K; Jakobsen Bent K. (2007) The HLA A*0201-restricted hTERT(540-548) peptide is not detected on tumor cells by a CTL clone or a high-affinity T-cell receptor. Molecular cancer therapeutics 2007; 6(7):2081-91.

Purbhoo Marco A; Sutton Deborah H; Brewer Joanna E; Mullings Rebecca E; Hill Maxine E; Mahon Tara M; Karbach Julia; Jäger Elke; Cameron Brian J; Lissin Nikolai; Vyas Paresh; Chen Ji-Li; Cerundolo Vincenzo; Jakobsen Bent K (2006) Quantifying and imaging NY-ESO-1/LAGE-1-derived epitopes on tumor cells using high affinity T cell receptors. Journal of immunology (Baltimore, Md. : 1950) 2006;176(12):7308-16.

Dunn Steven M; Rizkallah Pierre J; Baston Emma; Mahon Tara; Cameron Brian; Moysey Ruth; Gao Feng; Sami Malkit; Boulter Jonathan; Li Yi; Jakobsen Bent K. (2006)  Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity. Protein science: a publication of the Protein Society 2006; 15(4):710-21.

Li Yi; Moysey Ruth; Molloy Peter E; Vuidepot Anne-Lise; Mahon Tara; Baston Emma; Dunn Steven; Liddy Nathaniel; Jacob Jansen; Jakobsen Bent K; Boulter Jonathan M. (2005)  Directed evolution of human T-cell receptors with picomolar affinities by phage display. Nature biotechnology 2005;23(3):349-54.

Boulter Jonathan M; Glick Meir; Todorov Penio T; Baston Emma; Sami Malkit; Rizkallah Pierre; Jakobsen Bent K. (2003) Stable, soluble T-cell receptor molecules for crystallization and therapeutics. Protein engineering 2003; 16(9):707-11